GAO Reports ACA Tax Credit Fraud; Medicare Drug Costs, Debt Risks Rise

A recent Government Accountability Office (GAO) report has exposed significant fraud in the Affordable Care Act (ACA) Premium Tax Credits program, with incidences of identity fraud, subsidy payments to deceased individuals, and multiple policies using the same Social Security numbers. This has led to wasteful spending and higher health care costs, highlighting weaknesses in program integrity controls. Concurrently, a report from the Committee for a Responsible Federal Budget warns that funding Social Security through general revenues could add over $150 trillion to the national debt over 75 years, increase debt-to-GDP ratio by over 130%, and undermine the program's self-funded structure, increasing fiscal risks without substantial reforms. The bond market currently appears stable but experts caution about potential sudden market disruptions due to investor herd behavior and extended low interest rates encouraging continued deficit spending without fiscal discipline. Additionally, the Congressional Budget Office (CBO) has underestimated Medicare Part D prescription drug costs, with private plan bids indicating a 35% annual cost increase for 2026 compared to CBO's initial 5% estimate, potentially increasing Medicare Part D spending by $500 billion over the next decade and adding to federal debt automatically through general revenue financing. Finally, a National Bureau of Economic Research (NBER) study suggests that congressional leaders outperform peers in stock trading after gaining leadership positions, raising concerns over possible conflicts of interest and the need for stronger enforcement of financial disclosure laws to maintain public trust.